{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:19:11Z","timestamp":1784852351899,"version":"3.55.0"},"reference-count":18,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"DOI":"10.1210\/jc.2012-2590","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T14:22:22Z","timestamp":1350570142000},"page":"4324-4328","source":"Crossref","is-referenced-by-count":27,"title":["Atypical Femur Fractures: 81 Individual Personal Histories"],"prefix":"10.1210","volume":"97","author":[{"given":"Jennifer P.","family":"Schneider","sequence":"first","affiliation":[{"name":"Arizona Community Physicians (J.P.S.), Tucson, Arizona 85712"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Hinshaw","sequence":"additional","affiliation":[{"name":"Markle & Hinshaw Gynecology (W.B.H.), Harris Regional Hospital, Sylva, North Carolina 28779"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Su","sequence":"additional","affiliation":[{"name":"IBM Global Services (C.S.), Armonk, New York 10504"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"Solow","sequence":"additional","affiliation":[{"name":"Portland Community College (P.S.), Portland, Oregon 97219"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113215691200_B1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215691200_B2","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy.","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215691200_B3","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215691200_B4","unstructured":"2011 Transcript for the September 9, 2011 joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee. Available for free access at http:\/\/www.fda.gov\/ as UCM275810.pdf"},{"key":"key\n\t\t\t\t2019041113215691200_B5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","article-title":"Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.","volume":"305","author":"Park-Wyllie","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113215691200_B6","first-page":"31","article-title":"Should bisphosphonates be continued indefinitely?","volume":"61","author":"Schneider","year":"2006","journal-title":"Geriatrics"},{"key":"key\n\t\t\t\t2019041113215691200_B7","first-page":"1546","article-title":"Evidence-based orthopedics: commentary.","volume":"93","author":"Lane","year":"2011","journal-title":"J Bone Joint Surg"},{"key":"key\n\t\t\t\t2019041113215691200_B8","article-title":"A retrospective analysis of atypical femur fractures in a large California HMO from the years 2007 to 2009","author":"Dell","year":"2010"},{"key":"key\n\t\t\t\t2019041113215691200_B9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","article-title":"Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.","volume":"172","author":"Meier","year":"2012","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113215691200_B10","unstructured":"FDA Drug Safety Communication: Safety update for osteoporosis drugs, bisphosphonates, and atypical fractures. Oct13, 2010. Accessible free at http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm229009.htm"},{"key":"key\n\t\t\t\t2019041113215691200_B11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","article-title":"Atypical fractures of the femur and bisphosphonate use. A systematic review of case\/case series studies.","volume":"47","author":"Giusti","year":"2010","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113215691200_B12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejrad.2007.01.014","article-title":"Stress fractures in the lower extremity: the importance of increasing awareness amongst radiologists.","volume":"62","author":"Berger","year":"2007","journal-title":"Eur J Radiol"},{"key":"key\n\t\t\t\t2019041113215691200_B13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1302\/0301-620X.92B5.22941","article-title":"A rational approach to management of alendronate- related subtrochanteric fractures.","volume":"92","author":"Das De","year":"2010","journal-title":"J Bone Joint Surg Br"},{"key":"key\n\t\t\t\t2019041113215691200_B14","article-title":"Stopping bisphosphonate treatment decreases the risk of having a second atypical femur fracture","author":"Dell"},{"key":"key\n\t\t\t\t2019041113215691200_B15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00198-009-0986-y","article-title":"Alendronate-related femoral diaphysis fracture\u2014what should be done to predict and prevent subsequent fracture of the contralateral side?","volume":"21","author":"Edwards","year":"2010","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113215691200_B16","first-page":"256","article-title":"Bisphosphonate-associated subtrochanteric stress fractures: an emerging epidemic.","volume":"94","author":"Ward","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"key\n\t\t\t\t2019041113215691200_B17","article-title":"Are screening radiographs necessary to detect incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy?","author":"Viera"},{"key":"key\n\t\t\t\t2019041113215691200_B18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1752-1947-6-50","article-title":"Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report.","volume":"6","author":"Imbuldeniya","year":"2012","journal-title":"J Med Case Rep"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/12\/4324\/9045265\/jcem4324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T20:08:18Z","timestamp":1562270898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/12\/4324\/2536343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-2590","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}